All In Biotech

Drug Trial Radar · NCT05765344

Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

A Phase 1, Open-label, Parallel-group, Multiple-dose Study to Evaluate the Pharmacokinetics of Bulevirtide in Participants With Normal and Impaired Hepatic Function

Last checked: Nov 20, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

74

Actual

Start

Mar 15, 2023

Primary completion

Jan 10, 2025

Study completion Jan 13, 2025

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Mar 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goals of this study are to measure the amount of bulevirtide (BLV) that gets into the blood stream and how long it takes to get rid of it, measure the effect of BLV on bile acids, and evaluate the safety and tolerability of multiple doses of BLV in participants with normal and impaired hepatic (liver) function.

Conditions

  • Hepatic Impairment
  • Healthy

Interventions

  • BulevirtideDrug

    2 mg administered via subcutaneous injections.

  • BulevirtideDrug

    10 mg administered via subcutaneous injections.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetic (PK) Parameter: AUCtau of Bulevirtide (BLV)Time frame: Day 6: Predose and up to 24 hours postdose
  2. PK Parameter: Cmax,ss of BLVTime frame: Day 6: Predose and up to 24 hours postdose

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Orange County Research Center

    Lake Forest, California

  • Clinical Pharmacology of Miami, LLC

    Miami, Florida

  • University of Miami

    Miami, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

  • Texas Liver Institute

    San Antonio, Texas

  • Pinnacle Clinical Research LLC

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.